Total synthesis of lysobactin

Area of Science:

• Microbiology
• Medicinal Chemistry
• Drug Discovery

Background:

• Antibiotic resistance is a major global health threat, necessitating the development of new drugs with novel mechanisms of action.
• Existing antibiotics are becoming less effective against multidrug-resistant bacterial strains.
• Lysobactin is a depsipeptide antibiotic with demonstrated potent activity against resistant pathogens.

Purpose of the Study:

• To evaluate the antibacterial activity of lysobactin against resistant bacterial strains.
• To investigate the mechanism of action of lysobactin.
• To develop a synthetic route for lysobactin and its analogues.

Main Methods:

• Minimum inhibitory concentration (MIC) assays were performed against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
• Lysobactin's effect on peptidoglycan formation was assessed.
• A convergent synthesis strategy involving macrocyclization was employed to produce lysobactin.

Main Results:

• Lysobactin exhibited strong antibacterial activity against MRSA and VRE, with MICs ranging from 0.39 to 0.78 microg/mL.
• Against VRE, lysobactin's MICs were over 50-fold lower than vancomycin.
• Lysobactin inhibited nascent peptidoglycan formation through a mechanism distinct from vancomycin.

Conclusions:

• Lysobactin is a promising candidate for treating infections caused by antibiotic-resistant bacteria.
• The distinct mechanism of action and potent activity make lysobactin valuable for further research.
• The developed synthesis provides a basis for creating and studying lysobactin analogues.